Nothing Special   »   [go: up one dir, main page]

AR030230A1 - Derivados de acilfenilurea, procedimiento para su preparacion y su empleo en la preparacion de medicamentos - Google Patents

Derivados de acilfenilurea, procedimiento para su preparacion y su empleo en la preparacion de medicamentos

Info

Publication number
AR030230A1
AR030230A1 ARP010102735A ARP010102735A AR030230A1 AR 030230 A1 AR030230 A1 AR 030230A1 AR P010102735 A ARP010102735 A AR P010102735A AR P010102735 A ARP010102735 A AR P010102735A AR 030230 A1 AR030230 A1 AR 030230A1
Authority
AR
Argentina
Prior art keywords
alkyl
alkylene
phenyl
cycloalkyl
coo
Prior art date
Application number
ARP010102735A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001116768 external-priority patent/DE10116768A1/de
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of AR030230A1 publication Critical patent/AR030230A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48—Y being a hydrogen or a carbon atom
    • C07C275/54—Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Derivados de acilfenilurea, de formula (1) en la cual: A representa fenilo, naftilo, pudiendo estar el radical fenilo o naftilo substituidos hasta tres veces con F, Cl, Br, OH, CF3, NO2, CN, OCF3, O-alquilo C1-6, O-alquenilo C1-6, O-alquinilo C1-6, S-alquilo C1-6, S-alquenilo C1-6, S-alquinilo C1-6, SO-alquilo C1-6, SO2-alquilo C1-6, SO2-NH2, alquilo C1-6, alquenilo C1-6, alquinilo C1-6, cicloalquilo C3-7, cicloalquil C3-7-alquileno C1-4, alquilen C0-6-COOH, alquilen C0-6-COO-alquilo C1-7, CONH2, CONH-alquilo C1-6, CON-(alquilo C1-6)2, CONH-cicloalquilo C3-6, alquilen C0-6-NH2, alquilen C0-6-NH-alquilo C2-6, alquilen C0-6-N-(alquilo C1-6)2, NH-CO-alquilo C1-6, Nh-CO-fenilo, NH-SO2-fenilo, pudiendo estar el anillo fenílico substituido hasta dos veces con F, Cl, CN, OH, alquilo C1-6, O-alquilo C1-6, CF3, OCF3, COOH, COO-alquilo C1-6 o CONH2; R1 y R2 independientemente entre sí representan H, alquilo C1-6, O-alquilo C1-6, CO-alquilo C1-6, COO-alquilo C1-6, alquileno C1-6-COOH, alquileno C1-6-COO-alquilo C1-6; R3, R4, R5 y R6 independientemente entre sí representan H, F, Br, Cl, OH, CF3, NO2, CN, OCF3, O-alquilo C1-6, O-alquenilo C1-6, O-alquinilo C1-6, S-alquilo C1-6, S-alquenilo C1-6, S-alquinilo C1-6, SO-alquilo C1-6, SO2-alquilo C1-6, SO2-NH2, alquilo C1-6, alquenilo C1-6, alquinilo C1-6, cicloalquilo C3-7, cicloalquil C3-7-alquileno C1-4, COOH, COO-alquilo C1-6, CONH2, CONH-alquilo C1-6, CON-(alquilo C1-6)2, CONH-cicloalquilo C3-7, NH2, NH-alquilo C1-6, N(alquilo C1-6)2, NH-CO-alquilo C1-6, NH-CO-fenilo, NH-SO2-fenilo, pudiendo estar el anillo fenílico substituido hasta dos veces con F, Cl, CN, OH, alquilo C1-6, O-alquilo C1-6, CF3, OCF3, COOH, COO-alquilo C1-6 o CONH2; X representa O o S; R7 representa alquilen C1-10-COOH, alquilen C6-10-COO-alquilo C1-6, alquilen C1-10-CONH2, alquilen C1-10-CONH-alquilo C1-6, alquilen C1-10-CON(alquilo C1-6)2, alquilen C1-10-NH2, alquilen C1-10-NH-alquilo C1-6, alquilen C1-10-N(alquilo C1-6)2, alquilen C1-10-B; B representa cicloalquilo C3-7, pirrolilo, imidazolilo, tiazolilo, azetidinilo, tienilo, piperidinilo, pirrolidinilo, morfolinilo, piridilmetilo o furilo, en los cuales el cicloalquilo, el fenilo, el pirrolilo, el imidazolilo, el tiazolilo, el azetidinilo, el tienil-metilo, el piperidinilo, el pirrolidinilo, el morfolinilo, el piridilo o el furilo pueden estar substituidos en cada caso hasta dos veces con Cl, F, CN, CF3, OCF3, COOH, COO-alquilo C1-6, CONH2, CONH-alquilo C1-6, CON-(alquilo C1-6)2, alquilo C1-6, OH, o O-alquilo C1-6; así como sus sales fisiologicamente tolerables; estando excluidos los compuestos de formula (2) así como los compuestos de la formula (1) en los cuales los radicales significan al mismo tiempo: A es fenilo; X es O; R1 es H, R7 es alquilo C1-4-B, y B es cicloalquilo C3-7, o heteroarilo. Procedimientos para su preparacion, medicamentos y el empleo de dichos derivados para la preparacion de un medicamento para el tratamiento de la diabetes tipo II.
ARP010102735A 2000-06-09 2001-06-07 Derivados de acilfenilurea, procedimiento para su preparacion y su empleo en la preparacion de medicamentos AR030230A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10028175 2000-06-09
DE2001116768 DE10116768A1 (de) 2001-04-04 2001-04-04 Acylphenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
AR030230A1 true AR030230A1 (es) 2003-08-13

Family

ID=26005991

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102735A AR030230A1 (es) 2000-06-09 2001-06-07 Derivados de acilfenilurea, procedimiento para su preparacion y su empleo en la preparacion de medicamentos

Country Status (28)

Country Link
US (1) US6506778B2 (es)
EP (1) EP1294682B1 (es)
JP (1) JP4510372B2 (es)
KR (1) KR20030007934A (es)
CN (1) CN1280266C (es)
AR (1) AR030230A1 (es)
AT (1) ATE265424T1 (es)
AU (2) AU2001262318B2 (es)
BR (1) BR0111457A (es)
CA (1) CA2411082A1 (es)
CZ (1) CZ20024003A3 (es)
DE (1) DE50102147D1 (es)
DK (1) DK1294682T3 (es)
EE (1) EE200200634A (es)
ES (1) ES2215902T3 (es)
HK (1) HK1056715A1 (es)
HR (1) HRP20020968A2 (es)
HU (1) HUP0301749A2 (es)
IL (1) IL153273A0 (es)
MX (1) MXPA02011458A (es)
NO (1) NO20025879L (es)
NZ (1) NZ523034A (es)
PL (1) PL359178A1 (es)
PT (1) PT1294682E (es)
SK (1) SK17252002A3 (es)
TR (1) TR200401029T4 (es)
WO (1) WO2001094300A1 (es)
YU (1) YU91002A (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125567B4 (de) * 2001-05-25 2004-08-26 Aventis Pharma Deutschland Gmbh Carbonamid substituierte Phenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PE20021091A1 (es) * 2001-05-25 2003-02-04 Aventis Pharma Gmbh Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
DE10139416A1 (de) * 2001-08-17 2003-03-06 Aventis Pharma Gmbh Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
US7078404B2 (en) 2002-04-11 2006-07-18 Sanofi-Aventis Deutschland Gmbh Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
IL164249A0 (en) * 2002-04-11 2005-12-18 Aventis Pharma Gmbh Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use
DE10215908B4 (de) * 2002-04-11 2005-08-18 Aventis Pharma Deutschland Gmbh Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel
US7223796B2 (en) 2002-04-11 2007-05-29 Sanofi-Aventis Deutschland Gmbh Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
US7049341B2 (en) 2002-06-07 2006-05-23 Aventis Pharma Deutschland Gmbh N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use
DE10225635C1 (de) * 2002-06-07 2003-12-24 Aventis Pharma Gmbh N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
US7262220B2 (en) * 2002-07-11 2007-08-28 Sanofi-Aventis Deutschland Gmbh Urea- and urethane-substituted acylureas, process for their preparation and their use
ATE443041T1 (de) * 2002-07-11 2009-10-15 Sanofi Aventis Deutschland Harnstoff- und urethan-substituierte acylharnstoffe, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE10231627B4 (de) * 2002-07-12 2006-03-09 Sanofi-Aventis Deutschland Gmbh Heterozyklisch substituierte Benzoylharnstoffe und ihre Verwendung als Arzneimittel
AU2003249937A1 (en) * 2002-07-12 2004-02-02 Sanofi-Aventis Deutschland Gmbh Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
US20040157922A1 (en) * 2002-10-04 2004-08-12 Aventis Pharma Deutschland Gmbh Carboxyalkoxy-substituted acyl-carboxyphenylurea derivatives and their use as medicaments
DE10246434B4 (de) * 2002-10-04 2005-08-04 Aventis Pharma Deutschland Gmbh Carboxyalkoxy-substituierte Acyl-carboxyphenyl-harnstoffderivate und ihre Verwendung als Arzneimittel
US7179941B2 (en) * 2003-01-23 2007-02-20 Sanofi-Aventis Deutschland Gmbh Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
DE10302452B4 (de) * 2003-01-23 2005-02-24 Aventis Pharma Deutschland Gmbh Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
DE10306502B4 (de) * 2003-02-17 2005-03-17 Aventis Pharma Deutschland Gmbh Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel
US7196114B2 (en) * 2003-02-17 2007-03-27 Sanofi-Aventis Deutschland Gmbh Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308351A1 (de) * 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308355A1 (de) * 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
US7501440B2 (en) 2003-03-07 2009-03-10 Sanofi-Aventis Deutschland Gmbh Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use
DE10309929B4 (de) * 2003-03-07 2006-02-23 Sanofi-Aventis Deutschland Gmbh Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung
DE10335092B3 (de) * 2003-08-01 2005-02-03 Aventis Pharma Deutschland Gmbh Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung
US7241787B2 (en) 2004-01-25 2007-07-10 Sanofi-Aventis Deutschland Gmbh Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
EP1586573B1 (en) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolones, processes for their preparation and their use as pharmaceuticals
US7963448B2 (en) * 2004-12-22 2011-06-21 Cognex Technology And Investment Corporation Hand held machine vision method and apparatus
WO2006113650A1 (en) * 2005-04-18 2006-10-26 Khan Saeed R Design and synthesis of novel tubulin polymerization inhibitors: bonzoylphenyluria (bpu) sulfur analogs
WO2006126695A1 (ja) * 2005-05-23 2006-11-30 Japan Tobacco Inc. ピラゾール化合物及びそれらピラゾール化合物を含んでなる糖尿病治療薬
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
WO2008062739A1 (fr) * 2006-11-20 2008-05-29 Japan Tobacco Inc. Pyrazoles et leur utilisation en tant que médicaments
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
US9708272B2 (en) 2014-08-29 2017-07-18 Tes Pharma S.R.L. Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase
CN109952292A (zh) 2016-10-14 2019-06-28 Tes制药有限责任公司 α-氨基-β-羧基己二烯二酸半醛去羧酶的抑制剂
TW202033516A (zh) 2018-11-20 2020-09-16 義大利商Ｔｅｓ製藥（股份）責任有限公司 α-胺基-β-羧基己二烯二酸半醛去羧酶之抑制劑

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH516578A (de) * 1967-11-02 1971-12-15 Bayer Ag Verfahren zur Herstellung von heterocyclische Acylaminogruppen enthaltenden Arylsulfonylharnstoffen mit blutdrucksenkender Wirkung
ZA793186B (en) * 1978-07-06 1981-02-25 Duphar Int Res New urea and thiourea compounds, method of preparing the new compounds, as well as insecticidal compositions on the basis of these compounds
EP0136745B1 (en) * 1983-09-01 1989-06-07 Duphar International Research B.V Benzoyl urea derivatives having anti-tumor activity
JPS60237056A (ja) * 1984-05-08 1985-11-25 Ishihara Sangyo Kaisha Ltd Ｎ−ベンゾイル−ｎ′−フエニルウレア系化合物及びそれらを含有する殺虫剤
DE3567642D1 (en) * 1984-07-05 1989-02-23 Duphar Int Res Benzoylurea compounds, and insecticidal and acaricidal compositions comprising same
DE3504749A1 (de) * 1985-02-08 1986-08-14 Schering AG, 1000 Berlin und 4709 Bergkamen Acylharnstoffe, insektizide mittel enthaltend diese verbindungen sowie verfahren zu ihrer herstellung
JPH0791248B2 (ja) * 1988-06-29 1995-10-04 富士写真フイルム株式会社 アルコキシもしくはアリールオキシベンゼン化合物の製造方法
DE4208778C1 (es) * 1992-03-17 1993-09-23 Schering Ag Berlin Und Bergkamen, 13353 Berlin, De
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
DK1294682T3 (da) 2004-08-02
US20020151586A1 (en) 2002-10-17
NZ523034A (en) 2004-07-30
CZ20024003A3 (cs) 2003-03-12
AU2001262318B2 (en) 2005-09-08
MXPA02011458A (es) 2003-04-25
IL153273A0 (en) 2003-07-06
ATE265424T1 (de) 2004-05-15
WO2001094300A1 (de) 2001-12-13
JP2003535843A (ja) 2003-12-02
CN1434796A (zh) 2003-08-06
JP4510372B2 (ja) 2010-07-21
HK1056715A1 (en) 2004-02-27
DE50102147D1 (de) 2004-06-03
AU6231801A (en) 2001-12-17
SK17252002A3 (sk) 2003-05-02
NO20025879D0 (no) 2002-12-06
HUP0301749A2 (hu) 2003-09-29
EP1294682A1 (de) 2003-03-26
NO20025879L (no) 2003-01-29
US6506778B2 (en) 2003-01-14
ES2215902T3 (es) 2004-10-16
TR200401029T4 (tr) 2004-06-21
PL359178A1 (en) 2004-08-23
HRP20020968A2 (en) 2005-02-28
BR0111457A (pt) 2003-06-24
KR20030007934A (ko) 2003-01-23
CN1280266C (zh) 2006-10-18
EE200200634A (et) 2004-04-15
EP1294682B1 (de) 2004-04-28
PT1294682E (pt) 2004-09-30
YU91002A (sh) 2006-05-25
CA2411082A1 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
AR030230A1 (es) Derivados de acilfenilurea, procedimiento para su preparacion y su empleo en la preparacion de medicamentos
AR040477A1 (es) Benzoilureas heterociclicamente sustituidas, procedimiento para su preparacion y su uso como farmacos
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
ECSP045483A (es) Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso
AR057131A1 (es) Derivados de purina como inmunomodulador
AR017182A1 (es) Compuestos de aminotiazol, inhibidores de las kinasas dependientes de ciclinas y las composiciones farmaceuticas que los contienen.
AR039689A1 (es) Difenilazetidinonas sustituidas, medicamentos que comprenden estos compuestos y su uso
AR043154A1 (es) Derivados sustituidos con nitrogeno de hexahidro-pirazino[1,2-a] pirimidin-4,7-diona, procedimientos para su preparacion y su uso como medicamentos
AR034282A1 (es) Derivados de difenilazetidinona, medicamentos que contienen estos compuestos, procedimiento para su preparacion, y su utilizacion para la preparacion de medicamentos
AR079541A1 (es) Compuestos sustituidos de n-(1h-indazol-4-il) imidazo (1,2-a) piridin-3-carboxamida como inhibidores de cfms
AR043059A1 (es) Derivados de indolil pirazinona utiles para el tratamiento de trastornos hiper-proliferativos
ECSP066314A (es) Derivados piridilo y su uso como agentes terapéuticos
NO20060974L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
AR045595A1 (es) Composiciones utiles como inhibidores de proteinas quinasas
AR036029A1 (es) Derivados de fenilurea sustituidos con carbonamida, procedimiento para preparacion, medicamentos y su empleo para la preparacion de medicamentos para el tratamiento de la diabetes tipo ii
AR078152A1 (es) Compuestos heterociclicos, utiles para el tratamiento de hcv y composiciones farmaceuticas que los comprenden
TW200626572A (en) Heterocyclic derivatives and their use as therapeutic agents
AR053554A1 (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
AR064471A1 (es) Macrociclos inhibidores selectivos del factor de coagulacion viia, composiciones farmaceuticas que los comprenden y uso de los mismos como agentes anticoagulantes.
AR043959A1 (es) Derivados de indolona-acetamida, procesos para prepararlos, composiciones farmaceuticas que los contienen y su uso como productos farmaceuticos
RU2010107603A (ru) Производные n-(2-тиазолил)амида для лечения ожирения, диабетов и сердечно-сосудистых заболеваний
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
EA200700901A1 (ru) Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии
AR045949A1 (es) Derivados de piridina, inhibidores de urotensina ii
AR047466A1 (es) Compuestos derivados de 3h - imidazo[4,5 - b]piridina con actividad inhibidora de quinasa, composiciones farmacéuticas que los contienen como principio activo y su uso en la fabricacion de un medicamento para el tratatmiento de neoplasmas susceptibles.

Legal Events

Date Code Title Description
FB Suspension of granting procedure